Equities

Scandion Oncology A/S

Scandion Oncology A/S

Actions
  • Price (SEK)2.95
  • Today's Change-0.09 / -2.97%
  • Shares traded97.52k
  • 1 Year change-82.84%
  • Beta0.4645
Data delayed at least 15 minutes, as of Feb 02 2023 17:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Scandion Oncology A/S is a manufacturer of biological products. The Company was founded in May 2017 and is located in Copenhagen, Denmark. It focuses on modern onclogy, the treatment of cancers that have developed resistance to chemotherapy.

  • Revenue in SEK (TTM)--
  • Net income in SEK--
  • Incorporated2017
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Dextech Medical AB0.00-5.14m89.29m1.00--2.35-----0.2966-0.29660.002.060.00-------23.11-36.80-23.29-38.28------------0.00------13.26---18.38--
ISR Immune System Rgultn Hldg AB (publ)0.00-257.16m96.61m-----------3.65-3.650.00-2.390.00-------1,169.75-111.37---155.17-----------128,581.00---------152.98------
PCI Biotech Holding ASA4.96m-76.64m99.72m17.00--1.51--20.11-1.97-1.970.12731.700.0416--0.5862279,529.40-64.25-33.17-72.79-36.55-----1,545.58-762.80----0.0221---14.86-9.75-22.36------
Lidds AB4.37m-36.67m102.55m3.00--2.19--23.48-0.9805-0.98050.11660.67330.0874--8.89---73.34-18.73-88.78-19.85-----839.40-878.39---18,330.500.00--930.15---15.27---29.79--
Bioextrax AB publ545.90k-15.78m106.89m----4.32--195.80-1.01-1.010.03470.9710.0332--3.26---95.97---123.03---86.52---2,890.40-----22,539.960.00--1,166.12---89.02------
Lipum AB (publ)0.00-54.24m108.69m----24.12-----11.98-11.980.000.58860.00-------144.61---166.87--------------0.3449---100.00---147.69------
Nordic Nanovector ASA0.00-453.04m116.67m40.00--0.6124-----4.20-4.200.001.570.00----0.00-107.68-69.82-153.00-88.28-------636,940.80----0.00-------5.81---29.60--
Scandion Oncology A/S-100.00bn-100.00bn123.59m----0.9448----------3.21----------------------------0.0072-------217.81------
Isofol Medical AB (publ)15.65m-195.59m126.63m15.00--0.6889--8.09-4.22-4.220.1241.140.0441--1.171,043,000.00-55.10-61.04-69.25-74.66-1,086.11---1,250.18-1,186.01----0.0023---39.63---5.96------
Coegin Pharma AB0.00-35.59m131.22m----5.37-----0.0516-0.05160.000.02640.00-------142.04---158.13-------------1,546.570.00------41.29------
Alzinova AB0.00-10.81m133.24m----1.21-----0.4388-0.43880.003.400.00-------10.34-8.30-10.66-8.62-----------476.840.00-------16.19--28.46--
Toleranzia AB0.00-8.14m134.03m----1.10-----0.0673-0.06730.001.100.00-------6.19-12.63-6.43-13.30------------0.0069-------27.68--55.48--
2cureX AB8.00k-28.86m137.30m----2.71--17,162.84-1.76-1.760.00052.880.0001--0.0011---42.42-23.18-44.73-27.65-176,600.00-88,517.02-360,787.50-94,872.34----0.00-------158.70---37.81--
Peptonic Medical AB36.14m-73.58m144.43m----0.8296--4.00-0.2277-0.22770.10750.14350.41881.043.39---85.26-38.78-113.84-45.5560.91---203.61-223.580.5254-38.840.2223---10.10---115.39---16.66--
Aqua Bio Technology ASA1.68m-23.68m153.18m2.00--19.31--91.08-1.13-1.130.08040.36770.06440.66061.50---90.75-73.71-152.91-100.31-117.42-41.86-1,408.30-2,046.060.3127-12.490.4955--250.98---33.32--56.78--
Xintela AB0.00-78.22m154.71m-----------0.5315-0.53150.00-0.00850.00-------302.11-119.65-559.20-180.99-------12,122.000.3763-17.76---------19.76--27.36--
Data as of Feb 02 2023. Currency figures normalised to Scandion Oncology A/S's reporting currency: Swedish Krona SEK

Institutional shareholders

0.25%Per cent of shares held by top holders
HolderShares% Held
Tellus Fonder ABas of 31 Aug 2020101.31k0.25%
Data from 31 Aug 2020 - 31 Aug 2020Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.